Literature DB >> 19549910

miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.

Nora Bandi1, Samuel Zbinden, Mathias Gugger, Marlene Arnold, Verena Kocher, Lara Hasan, Andreas Kappeler, Thomas Brunner, Erik Vassella.   

Abstract

MicroRNAs (miRNA) are negative regulators of gene expression at the posttranscriptional level, which are involved in tumorigenesis. Two miRNAs, miR-15a and miR-16, which are located at chromosome 13q14, have been implicated in cell cycle control and apoptosis, but little information is available about their role in solid tumors. To address this question, we established a protocol to quantify miRNAs from laser capture microdissected tissues. Here, we show that miR-15a/miR-16 are frequently deleted or down-regulated in squamous cell carcinomas and adenocarcinomas of the lung. In these tumors, expression of miR-15a/miR-16 inversely correlates with the expression of cyclin D1. In non-small cell lung cancer (NSCLC) cell lines, cyclins D1, D2, and E1 are directly regulated by physiologic concentrations of miR-15a/miR-16. Consistent with these results, overexpression of these miRNAs induces cell cycle arrest in G(1)-G(0). Interestingly, H2009 cells lacking Rb are resistant to miR-15a/miR-16-induced cell cycle arrest, whereas reintroduction of functional Rb resensitizes these cells to miRNA activity. In contrast, down-regulation of Rb in A549 cells by RNA interference confers resistance to these miRNAs. Thus, cell cycle arrest induced by these miRNAs depends on the expression of Rb, confirming that G(1) cyclins are major targets of miR-15a/miR-16 in NSCLC. Our results indicate that miR-15a/miR-16 are implicated in cell cycle control and likely contribute to the tumorigenesis of NSCLC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19549910     DOI: 10.1158/0008-5472.CAN-08-4277

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  161 in total

1.  Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action.

Authors:  Seyed H Ghaffari; Davood Bashash; Majid Zaki Dizaji; Ardeshir Ghavamzadeh; Kamran Alimoghaddam
Journal:  Tumour Biol       Date:  2011-11-10

2.  Terminal uridyltransferase enzyme Zcchc11 promotes cell proliferation independent of its uridyltransferase activity.

Authors:  Matthew T Blahna; Matthew R Jones; Lee J Quinton; Kori Y Matsuura; Joseph P Mizgerd
Journal:  J Biol Chem       Date:  2011-10-17       Impact factor: 5.157

Review 3.  MicroRNA sponges: progress and possibilities.

Authors:  Margaret S Ebert; Phillip A Sharp
Journal:  RNA       Date:  2010-09-20       Impact factor: 4.942

Review 4.  The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases.

Authors:  John R Finnerty; Wang-Xia Wang; Sébastien S Hébert; Bernard R Wilfred; Guogen Mao; Peter T Nelson
Journal:  J Mol Biol       Date:  2010-08-01       Impact factor: 5.469

5.  Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas.

Authors:  X Zhang; X Chen; J Lin; T Lwin; G Wright; L C Moscinski; W S Dalton; E Seto; K Wright; E Sotomayor; J Tao
Journal:  Oncogene       Date:  2011-10-17       Impact factor: 9.867

6.  miR-15a enhances the anticancer effects of cisplatin in the resistant non-small cell lung cancer cells.

Authors:  Vildan Bozok Çetintaş; Aslı Tetik Vardarlı; Zekeriya Düzgün; Burçin Tezcanlı Kaymaz; Eda Açıkgöz; Hüseyin Aktuğ; Buket Kosova Can; Cumhur Gündüz; Zuhal Eroğlu
Journal:  Tumour Biol       Date:  2015-08-28

7.  An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state.

Authors:  Christos Polytarchou; Dimitrios Iliopoulos; Kevin Struhl
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

Review 8.  Cyclin D1, cancer progression, and opportunities in cancer treatment.

Authors:  Shuo Qie; J Alan Diehl
Journal:  J Mol Med (Berl)       Date:  2016-10-02       Impact factor: 4.599

Review 9.  MicroRNA as tools and therapeutics in lung cancer.

Authors:  Jennifer F Barger; S Patrick Nana-Sinkam
Journal:  Respir Med       Date:  2015-02-19       Impact factor: 3.415

10.  Conservation of miR-15a/16-1 and miR-15b/16-2 clusters.

Authors:  Junming Yue; Gabor Tigyi
Journal:  Mamm Genome       Date:  2009-12-16       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.